Twist Bioscience Corporation (BIT:1TWST)
Italy
· Delayed Price · Currency is EUR 29.09
+1.43 (5.17%)
At close: May 12, 2025
Revenue by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Next Generation Sequencing Tools | 169.13M |
Log In |
Log In |
Log In |
Log In |
| Next Generation Sequencing Tools Growth | 36.72% |
Log In |
Log In |
Log In |
Log In |
| Synthetic Genes | 92.68M |
Log In |
Log In |
Log In |
Log In |
| Synthetic Genes Growth | 26.02% |
Log In |
Log In |
Log In |
Log In |
| Antibody Discovery | 20.33M |
Log In |
Log In |
Log In |
Log In |
| Antibody Discovery Growth | -12.27% |
Log In |
Log In |
Log In |
Log In |
| Oligo Pools | 16.91M |
Log In |
Log In |
Log In |
Log In |
| Oligo Pools Growth | 16.68% |
Log In |
Log In |
Log In |
Log In |
| DNA Libraries | 13.93M |
Log In |
Log In |
Log In |
Log In |
| DNA Libraries Growth | 36.58% |
Log In |
Log In |
Log In |
Log In |
| DNA and Biopharma Libraries | - |
Log In |
Log In |
Log In |
Log In |
| DNA and Biopharma Libraries Growth | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| United States | 187.78M |
Log In |
Log In |
Log In |
Log In |
| United States Growth | 27.69% |
Log In |
Log In |
Log In |
Log In |
| EMEA | 92.57M |
Log In |
Log In |
Log In |
Log In |
| EMEA Growth | 29.67% |
Log In |
Log In |
Log In |
Log In |
| APAC | 26.52M |
Log In |
Log In |
Log In |
Log In |
| APAC Growth | 18.11% |
Log In |
Log In |
Log In |
Log In |
| Americas | 6.10M |
Log In |
Log In |
Log In |
Log In |
| Americas Growth | 45.31% |
Log In |
Log In |
Log In |
Log In |